Literature DB >> 11350396

The current status of interferon-alpha treatment in advanced renal cancer.

J Stebbing1, M Gore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11350396     DOI： 10.1046/j.1464-410x.2001.02140.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

1.  Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma.

Authors:  D F R Griffiths; N Nind; C J O'Brien; M Rashid; A Verghese
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma.

Authors:  Michael Huie; Kurt Oettel; Lynn Van Ummersen; Kyung Mann Kim; Yulin Zhang; Mary Jane Staab; Dottie Horvath; Rebecca Marnocha; Jeff Douglas; Amy Drezen; Dona Alberti; George Wilding
Journal:  Invest New Drugs       Date:  2006-05       Impact factor: 3.651
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.